Profile data is unavailable for this security.
About the company
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA); Americas; and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels, and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion, and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.
- Revenue in GBP (TTM)977.50m
- Net income in GBP103.20m
- Incorporated2020
- Employees2.59k
- LocationDr Martens PLC28 Jamestown Rd, CamdenLONDON NW1 7BYUnited KingdomGBR
- Websitehttps://www.drmartensplc.com/
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
HSBC Private Bank (UK) Ltd.as of 01 Apr 2024 | 56.08m | 5.83% |
Artemis Investment Management LLPas of 07 Jul 2023 | 50.89m | 5.29% |
GIC Pte Ltd. (Investment Management)as of 27 Jul 2023 | 50.04m | 5.20% |
BlackRock Investment Management (UK) Ltd.as of 31 Mar 2023 | 40.08m | 4.17% |
Royal London Asset Management Ltd.as of 01 Apr 2024 | 36.77m | 3.82% |
FIL Investment Advisors (UK) Ltd.as of 01 Apr 2024 | 30.19m | 3.14% |
The Vanguard Group, Inc.as of 01 Apr 2024 | 19.93m | 2.07% |
Jupiter Asset Management Ltd.as of 01 Apr 2024 | 14.63m | 1.52% |
Norges Bank Investment Managementas of 01 Apr 2024 | 13.13m | 1.37% |
T. Rowe Price Associates, Inc. (Investment Management)as of 01 Apr 2024 | 9.22m | 0.96% |